SLF1081851 (TFA) is a Spns2 inhibitor, inhibits S1P release ( IC 50 =1.93 μM). SLF1081851 (TFA) plays a key role in development and immune system.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > LPL Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.